669P TG01/GM-CSF and adjuvant gemcitabine in patients with resected RAS-mutant adenocarcinoma of the pancreas.
Dueland, S Bell, K Faluyi, O Staiger, Helen Gjertsen, T Møller, A Aksnes, A Palmer, D
Dueland, S
Bell, K
Faluyi, O
Staiger, Helen
Gjertsen, T
Møller, A
Aksnes, A
Palmer, D
Citations
Altmetric:
Abstract
Description
Date
2017-09
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
669P TG01/GM-CSF and adjuvant gemcitabine in patients with resected RAS-mutant adenocarcinoma of the pancreas. 2017, 28(suppl_5): Ann Oncol